The efficacy of aggressive surveillance programs for patients with colorectal cancer remains unproven. Although they have increased rates of resection, they have not reliably increased survival. For the majority of patients, intensive follow-up is not warranted as they have localized disease which is unlikely to recur after appropriate treatment, disseminated disease, or are poor candidates for additional surgery.
|Original language||English (US)|
|Number of pages||23|
|Journal||Gastrointestinal Endoscopy Clinics of North America|
|State||Published - Jan 1 1993|